UBS Maintains Neutral on ArcBest, Raises Price Target to $145

Benzinga · 07/07 13:33
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $122 to $145.